Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

155 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The evolutionarily conserved long non-coding RNA LINC00261 drives neuroendocrine prostate cancer proliferation and metastasis via distinct nuclear and cytoplasmic mechanisms.
Mather RL, Parolia A, Carson SE, Venalainen E, Roig-Carles D, Jaber M, Chu SC, Alborelli I, Wu R, Lin D, Nabavi N, Jachetti E, Colombo MP, Xue H, Pucci P, Ci X, Hawkes C, Li Y, Pandha H, Ulitsky I, Marconett C, Quagliata L, Jiang W, Romero I, Wang Y, Crea F. Mather RL, et al. Among authors: nabavi n. Mol Oncol. 2021 Jul;15(7):1921-1941. doi: 10.1002/1878-0261.12954. Epub 2021 Apr 26. Mol Oncol. 2021. PMID: 33793068 Free PMC article.
Long non-coding RNAs in the doxorubicin resistance of cancer cells.
Ashrafizaveh S, Ashrafizadeh M, Zarrabi A, Husmandi K, Zabolian A, Shahinozzaman M, Aref AR, Hamblin MR, Nabavi N, Crea F, Wang Y, Ahn KS. Ashrafizaveh S, et al. Among authors: nabavi n. Cancer Lett. 2021 Jun 28;508:104-114. doi: 10.1016/j.canlet.2021.03.018. Epub 2021 Mar 22. Cancer Lett. 2021. PMID: 33766750 Review.
The long and short non-coding RNAs modulating EZH2 signaling in cancer.
Mirzaei S, Gholami MH, Hushmandi K, Hashemi F, Zabolian A, Canadas I, Zarrabi A, Nabavi N, Aref AR, Crea F, Wang Y, Ashrafizadeh M, Kumar AP. Mirzaei S, et al. Among authors: nabavi n. J Hematol Oncol. 2022 Mar 2;15(1):18. doi: 10.1186/s13045-022-01235-1. J Hematol Oncol. 2022. PMID: 35236381 Free PMC article. Review.
Metabolic heterogeneity signature of primary treatment-naïve prostate cancer.
Lin D, Ettinger SL, Qu S, Xue H, Nabavi N, Choi SYC, Bell RH, Mo F, Haegert AM, Gout PW, Fleshner N, Gleave ME, Pollak M, Collins CC, Wang Y. Lin D, et al. Among authors: nabavi n. Oncotarget. 2017 Apr 18;8(16):25928-25941. doi: 10.18632/oncotarget.15237. Oncotarget. 2017. PMID: 28460430 Free PMC article.
The long noncoding RNA landscape of neuroendocrine prostate cancer and its clinical implications.
Ramnarine VR, Alshalalfa M, Mo F, Nabavi N, Erho N, Takhar M, Shukin R, Brahmbhatt S, Gawronski A, Kobelev M, Nouri M, Lin D, Tsai H, Lotan TL, Karnes RJ, Rubin MA, Zoubeidi A, Gleave ME, Sahinalp C, Wyatt AW, Volik SV, Beltran H, Davicioni E, Wang Y, Collins CC. Ramnarine VR, et al. Among authors: nabavi n. Gigascience. 2018 Jun 1;7(6):giy050. doi: 10.1093/gigascience/giy050. Gigascience. 2018. PMID: 29757368 Free PMC article.
155 results